Spinifex makes two appointments
This article was originally published in Scrip
Spinifex Pharmaceuticals, a company developing new drugs for the treatment of chronic pain, has made two new appointments to enhance its chemistry, manufacturing and controls (CMC) capabilities. Dr Peter Spargo has joined Spinifex as senior vice-president, CMC. Previously Dr Spargo acted as an industry consultant, including to Spinifex, and held the role of SVP CMC at Creabilis (Italy and UK) and at Novexel (France).